ADASUVE

Active substance

Inhalation powder loxapine (pre-dispensed)

Pharmaceutical Form

9,1 mg inhalation powder of loxapine for oral inhalation use

Adasuve R-24 - LOI - PI comments - FINAL (europa.eu)

Therapeutic Category

Acute treatment of mild to moderate agitation in adults patients with schizophrenia or bipolar disorder

Note:
This content is intended for informational purposes only and in no way it can replace the advice of a doctor or other qualified health care professional.